EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utility of ISARIC 4C Mortality Score, Vaccination History, and Anti-S Antibody Titre in Predicting Risk of Severe COVID-19

Lin Pin Koh, Travis Ren Teen Chia, Samuel Sherng Young Wang iD, Jean-Marc Chavatte iD, Robert Hawkins, Yonghan Ting iD, Jordan Zheng Ting Sim iD, Wen Xiang Chen, Kelvin Bryan Tan, Cher Heng Tan, David Chien Lye iD, Barnaby E Young

Viruses · 2024

DOI: 10.3390/v16101604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Lin Pin Koh und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Infectious Diseases, Singapore 308442, Singapore. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Vaccination, COVID-19 Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Singapore National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ISARIC 4C Mortality score was developed to predict mortality risk among patients with COVID-19. Its performance among vaccinated individuals is understudied. This is a retrospective study of all patients with SARS-CoV-2 infection admitted to the National Centre for Infectious Diseases, Singapore, from January-2020 to December-2021. Demographic, clinical, and laboratory data were extracted, and multiple logistic regression (MLR) models were developed to predict the relationship between ISARIC score, vaccination status, anti-S antibody titre, and severe COVID-19. A total of 6377 patients were identified, of which 5329 met the study eligibility criteria. The median age of the patients was 47 years (IQR 35–71), 1264 (23.7%) were female, and 1239 (25.7%) were vaccinated. Severe disease occurred in 499 (9.4%) patients, including 133 (2.5%) deaths. After stratification, 3.0% of patients with low (0–4), 17.8% of patients with moderate (5–9), and 36.2% of patients with high (≥10) ISARIC scores developed severe COVID-19. Vaccination was associated with a reduced risk of progression to severe COVID-19 in the MLR model: aOR 0.88 (95% CI: 0.86–0.90), and the risk of severe COVID-19 decreased inversely to anti-S antibody titres. The anti-S antibody titre should be further investigated as an adjunct to the ISARIC score to triage COVID-19 patients for hospital admission and antiviral therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2VaccinationCOVID-19 VaccinesAntibodies, ViralHumansFemaleMiddle AgedMaleRetrospective StudiesAgedAdultSeverity of Illness IndexSingaporeRisk Factors

Stichwörter der Autor:innen

COVID-19ISARICSARS-CoV-2modellingserologyvaccination

Substanzen

COVID-19 VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • National Centre for Infectious Diseases, Singapore 308442, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
  • Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore 308433, Singapore.
  • Department of Laboratory Medicine, Tan Tock Seng Hospital, Singapore 308433, Singapore.
  • Department of Radiology, Tan Tock Seng Hospital, Singapore 308433, Singapore.
  • Ministry of Health, 16 College Road, College of Medicine Building, Singapore 169854, Singapore.

ORCID-Profile: Samuel Sherng Young Wang, Jean-Marc Chavatte, Yonghan Ting, Jordan Zheng Ting Sim, David Chien Lye

Förderung

  • Singapore National Medical Research Council

Zitieren

APA

Koh, L. P., Chia, T. R. T., Wang, S. S. Y., Chavatte, J. M., Hawkins, R., Ting, Y., Sim, J. Z. T., Chen, W. X., Tan, K. B., Tan, C. H., Lye, D. C., & Young, B. E. (2024). Utility of ISARIC 4C Mortality Score, Vaccination History, and Anti-S Antibody Titre in Predicting Risk of Severe COVID-19. Viruses. https://doi.org/10.3390/v16101604

Vancouver

Koh LP, Chia TRT, Wang SSY, Chavatte JM, Hawkins R, Ting Y, et al. Utility of ISARIC 4C Mortality Score, Vaccination History, and Anti-S Antibody Titre in Predicting Risk of Severe COVID-19. Viruses. 2024. doi:10.3390/v16101604

BibTeX
@article{Koh2024,
  author = {Koh, Lin Pin and Chia, Travis Ren Teen and Wang, Samuel Sherng Young and Chavatte, Jean-Marc and Hawkins, Robert and Ting, Yonghan and Sim, Jordan Zheng Ting and Chen, Wen Xiang and Tan, Kelvin Bryan and Tan, Cher Heng and Lye, David Chien and Young, Barnaby E},
  title = {Utility of ISARIC 4C Mortality Score, Vaccination History, and Anti-S Antibody Titre in Predicting Risk of Severe COVID-19},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16101604}
}
Kostenlos starten →